
Simultaneous targeting PI3K and PERK pathways promotes cell death and improves the clinical prognosis in esophageal squamous carcinoma
Keywords: ESCC; PI3K; mTOR; PERK; LY294002; GSK2656157; Activating transcription factor 4; ATF4; Esophageal adenocarcinoma; EAC; Esophageal squamous cell carcinoma; ESCC; eukaryotic translation initiation factor 2-alpha; elF2α; phosphorylated elF2α; p-elF2α; Ove